Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.76%
623.92
+4.71
+0.76%
—619.21618.96624.43615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+1.64%
539.56
+8.70
+1.64%
—530.86530.03539.70526.25——
SX8P
Technology
SX8P
Technology
SX8P
+0.48%
935.10
+4.48
+0.48%
—930.62924.86942.94921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-0.06%
455.77
-0.28
-0.06%
—456.05452.80456.46446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
+0.24%
1,093.21
+2.58
+0.24%
—1,090.631,086.801,093.131,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+1.05%
540.95
+5.61
+1.05%
—535.34536.16545.74536.16——
SXFP
Financials
SXFP
Financials
SXFP
+1.17%
900.61
+10.38
+1.17%
—890.23887.34900.61883.68——
SXKP
Communications
SXKP
Communications
SXKP
+1.78%
318.34
+5.56
+1.78%
—312.78311.95319.44310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
+1.13%
1,107.93
+12.33
+1.13%
—1,095.601,090.801,109.451,082.31——
SXPP
Materials
SXPP
Materials
SXPP
+0.81%
824.71
+6.64
+0.81%
—818.07813.89826.30804.46——
301333:SHE
R&G PharmaStudies Co Ltd
CNÂ¥56.86
-1.15%
(-0.66) 1D
May 18, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301333...
Open
CNÂ¥57.50
High
CNÂ¥57.72
Low
CNÂ¥56.30
Mkt. cap
5.56B
Avg. vol.
2.08M
Volume
995.51K
P/E ratio
40.81
52-wk high
CNÂ¥91.78
52-wk low
CNÂ¥43.05
EPS
CNÂ¥1.39
Shares outstanding
96.58M
No. of employees
3K
News stories
From sources across the web
About R&G PharmaStudies Co Ltd
CEO-
Employees2.64K
FoundedAug 22, 2008
Headquarters-
SectorHealth care
Websiterg-pharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
206.82M
227.71M
243.64M
218.09M
Cost of goods sold
128.24M
153.16M
164.25M
152.25M
Cost of revenue
128.24M
153.16M
164.25M
152.25M
Research and development expenses
16.20M
15.10M
16.19M
15.51M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
24.96M
22.99M
30.78M
23.05M
Operating expense
44.70M
38.00M
50.32M
38.71M
Total operating expenses
172.94M
191.16M
214.57M
190.96M
Operating income
33.88M
36.55M
29.07M
27.13M
Other non operating income
-55.64K
-1.56M
1.43M
-2.40M
EBT including unusual items
41.19M
39.46M
45.33M
25.76M
EBT excluding unusual items
36.45M
40.16M
32.65M
26.82M
Income tax expense
6.06M
4.17M
3.87M
2.88M
Effective tax rate
14.71%
10.56%
8.54%
11.16%
Other operating expenses
1.13M
1.04M
1.05M
153.53K
Net income
35.04M
34.45M
41.33M
22.83M
Net profit margin
16.94%
15.13%
16.96%
10.47%
Earnings per share
-
-
-
-
Interest and investment income
3.98M
5.23M
6.24M
2.09M
Interest expense
-784.67K
-623.53K
-623.36K
-
Net interest expenses
3.19M
4.61M
5.62M
2.09M
Depreciation and amortization charges
-
-
-
-
EBITDA
35.58M
38.49M
30.77M
28.83M
Gain or loss from assets sale
-
-
9.34K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer